SlideShare a Scribd company logo
LEUKEMIAS
Guided by:
Dr.Ami shah
Moderated by:
Dr.Priyanka gohel
Presented by:
Jaimin Manek
What is “Leukemia???
 Leukemia: is characterized by abnormal
proliferation of blood cells,usually
WBCs(Leukocytes).
 Acute leukemia: rapid increase of immature
blood cells.
 Chronic leukemia: excessive build up of
relatively mature, but still abnormal blood cells.
 Leukemia results
- From somatic mutations in the DNA.
- By activating oncogenes or deactivating
tumor suppressor genes.
FACTORS:
 Ionizing radiation
 Viruses: HumanT-lymphotropic virus (HTLV-1)
 Chemicals: Benzene,chemotherapy.
 Smoking: slight increase in leukemia incidence.
 Genetic predisposition: Down syn.,Fanconi anemia
Normal hemopoiesis is finely tuned by hemostatic
feedback mechanisms involving cytokines and
growth factors that modulate the marrow output of
red cells, granulocytes and platelets.
These mechanisms are deranged in marrows involved
by myeloid neoplasms.
Loss of control on growth & survival and suppressor
fuctions.
CSBRP-SDUMC-Oct-2014
Main groups:
1-Myeloid (acute / chronic)
2-Lymphoid (acute / chronic)
3-Mixed lineage leukemias
CSBRP-SDUMC-Oct-2014
 The most common malignant
neoplasms of childhood are Leukemias
 Which one is the commonest type of
childhood Leukemias?
AML 10%
ALL 80%
CML 2-3%
JCML 1-2%
Myeloblast Promyelocyte Myelocyte Metamyelocyte Band Neutrophil
MATURATION
Adapted and modified from U Va website
Myeloid maturation:
Two types of classifications:
1- FAB classification
- degree of maturation & lineage of blasts
- usage of cytochemistry & IHC
2-WHO classification
- degree of maturation & lineage of blasts
- Immunophenotyping
- cytogenetic & molecular features
- clinical outcome
CSBRP-SDUMC-Oct-2014
1. M0: minimally differentiated
2. M1: myeloblastic leukemia without maturation
3. M2: myeloblastic leukemia with maturation
4. M3: hypergranular promyelocytic leukemia
5. M4: myelomonocytic leukemia
6. M4Eo: variant, increase in marrow eosinophils
7. M5: monocytic leukemia
8. M6: erythroleukemia (DiGuglielmo's disease)
9. M7: megakaryoblastic leukemia
1. AML with recurrent genetic abnormalities
2. AML and MDS
3. AML -Tx related
4. AML not otherwise categorised
5. Myeloid Sarcoma
6. Myeloid proliferation related to Down
Syndrome
 Most of the signs and symptoms are due to:
1-Anemia.
2-Leukopenia.
3-Thrombocytopenia.
 Bicytopenia, Pancytopenia.
 All symptoms associated with leukemia
can be attributed to other diseases,
consequently, leukemia is always
diagnosed by laboratory investigations.
CSBRP-SDUMC-Oct-2014
CSBRP-SDUMC-Oct-2014
CSBRP-SDUMC-Oct-2014
CSBRP-SDUMC-Oct-2014
CSBRP-SDUMC-Oct-2014
 AML M0, M1, M2 : Chloromas
 AML M3 : DIC
 AML M4, M5 : Gum hypertrophy
 AML M7 : Mediastinal mass
(germ cell tumors)
CSBRP-SDUMC-Oct-2014
1. CBC a. Anemia
b. Trombocytopenia
c. WBC
High Normal Low
2. Coagulation Studies (M3-DIC)
3. Biochemical Studies
Bone marrow (>20% blasts)
- Morphology
- Cytochemistry
- Immunophenotyping
- Cytogenetics
Peripheral blood examination
 blasts in almost all cases
Molecular Genetic Analysis
The diagnostic requisite of 20 percent type I and II
myeloblasts in the peripheral blood or bone marrow.
BLAST Equivalents:
1. In AML (M3), the predominant leukemic cell is
promyelocyte
2. In AML (M5A), the predominant proliferating cell is the
monoblast
3. In AML (M5B), the predominant cell is the
promonocyte.
4. The megakaryoblasts of acute megakaryoblastic
leukemia vary in morphology but uniformly lack the
cytochemical properties of myeloblasts.CSBRP-SDUMC-Oct-2014
 < 1% of the normal bone marrow, not observed in
normal blood
 Vary in size, but are usually large
 Nucleus is delicate, large, round or oval, with
prominent nucleoli. Stain purplish red with
Wright stain. Chromatin stains evenly
 Small to moderate amount of bluish nongranular
cytoplasm
 Three major types:Type I, II, and III
 Fine nuclear chromatin
 2 to 4 distinct nucleoli
 Moderate rim of pale to basophilic
cytoplasm
 Without azurophilic granules
Type II
Delicate azurophilic granules in
the cytoplasm (up to 20)
Type III
Numerous azurophilic granules
in the cytoplasm
Monoblast Myeloblast

 Erythroblast
Megakaryoblast Lymphoblast
CYTOLOGIC FEATURES OF BLASTS IN AML & ALL
AML ALL
Blast size Medium to large, uniform Variable Small to medium
Cytoplasm
Fine granules may be
present
Usually scant, a few coarse
granules may be seen
Auer rods
Present in 60-70% of
cases
absent
Nuclear
chromatin
Finely dispersed Fine to coarse
Nucleoli 2-4, prominent 1-3, indistinct
Is an azurophilic linear structure (Single or multiple)
present in numerous blasts or in rare cells
• Present approximately 60 to 70 % of cases of AML.
• MPO, SBB, and CAE positive
The presence of an Auer rod in one or more blasts is
definitive evidence of AML.
(The finding is not specific for any one type of AML.)
CYTOCHEMICAL PROFILES OF ACUTE LEUKEMIAS
MPO
/ SBB
CAE NSE PAS AP
ALL _ _ + / -
Focally
+
75%
+ / -
Focal in T-
ALL
AML + +
+
Monocytic-
diffuse
- / + +
MPO-myeloperoxidase, SBB-Sudan balck B, CAE-chloracetate esterase, NSE-
non specific esterase, PAS-periodic acid schiff, AP-acid phosphataseCSBRP-SDUMC-Oct-2014
cvcv
Myeloperoxidase
(MPO)
p-Phenylene diamine +Catecol + H2O2
MPO > Brown black deposits
 It is a direct stain phospholipid in granular membrane.
 Auer rods are MPO and SBB positive.
Chloracetate (Specific)
Esterase
Myeloid Cell Line
Naphthol-ASD-chloracetate
Free naphthol compounds
+
Stable diazonium salt
Red deposit
FAB Immunological marker
AML with minimally differentiated CD13,CD34, HLA-DR,
CD33,CD117,CD2,CD7,TdT
AML without maturation CD13,CD14,CD33, CD34
AML with maturation and with
t(8;21)
CD34,CD56
Acute promyelocytic leukemia CD13,CD33, HLA-DR absent, CD34
negative
Acute myelomonocytic leukemia
with abnormal eosinophils and
inversion 16
CD13,CD34,CD11b,CD11c,CD14,CD33
Acute monocytic leukemia and 11q23
abnormalties
CD14,CD4,CD36,CD64
Erythroleukemia Glycophorin 7,Transferrin receptor CD71
Acute Megakaryocytic leukemia cCD41,cCD42b,cCD61
Chromosomal
Abnormality
Leukemia
t(8;21) M2
t(15;17) M3
inv, del, t(16q) M4
t(9;11) M5 (M5a); M4
 5% of AML cases
 No definite evidence of myeloid differentiation can be given by
morphology & cytochemistry.
 Blasts resembles M1 blast and L2 Lymphoblast
PS: Large cells with pale grey blue CYTOPLASM
NUCLEUS has opened fine chromatin with >= 1 nucleoli
Cytochemistry:
< 3% blasts reactive for MPO, SBB or NSE
Immunophenotyping:
 20% blasts express one or more myeloid antigens: CD13,
CD14, CD33
 may beTdT positive;
AML-M0 Bone marrow smear, May-Giemsa stain, x1000
AML M0 Bone marrow smear, cyMPO stain, x1000
15-20% of all AML cases
M1 is differentiated from M2 by the fact that
>90% blasts of non erythroid cells
<10% of marrow nucleated cells are promyelocytes or more
mature neutrophils
PS: Blasts have variable N/C ratio with pale basophilic CYTOPLASM
NUCLEUS has 1-4 nucleoli
Cytochemistry:>3% blasts reactive for MPO or SBB.
Immunophenotyping: Blasts express myeloid antigens: CD13, CD14,
CD33.
BLOOD SMEAR BONE MARROW SMEAR
BLAST WITH PALE TO BASOPHILIC AGRANULAR CYTOPLASM ,
NUCLEI WITH FINE CHROMATIN & PROMINENT NUCLEOLI
Commonest (30%) of all AML
Evidence of maturation to promyelocytes and more mature
neutrophils in 10 percent or more of the cells.
PS: Blasts are large with pale basophilic CYTOPLASM
NUCLEUS: oval to indented with 2-3 nucleoli
Cytochemistry: MPO, SBB, CEA +ve
Immunophenotyping: CD15, CD13, CD33 +ve
In t(8,21) associated cells: Pathognomonic
40-80% are positive for CD19
20% areTdT positive
AML M2 CASE 1 Bone marrow smear, MGG x200
A form of AML characterized primarily by a
proliferation of abnormal promyelocytes.
It is usually accompanied by
• DIC
• t(15;17)
The disease presents in two morphologic types:
1) hypergranular APL
predominant cell is an abnormal promyelocyte with
markedly increased and coarse azurophilic granules
2) microgranular or hypogranular APL
predominant cell is an abnormal promyelocyte with
diminished or small azurophilic granules.
The most common presenting symptoms, occurring in
90 % of patients, relate to hemorrhagic manifestations
and include
easy bruisability,
bleeding gums,
hemoptysis,
epistaxis, petechiae,
symptoms of gastrointestinal &
intracranial hemorrhage.
Basic pathology is DIC.
BONE MARROW SMEAR
HYPERGRANULAR
Nucleus : Folded, lobulated, granular
obscure border.
Cytoplasm: Prominent Azurophilic
granules.
Auer rods: Frequent, FAGGOT cells
( cells with bundles of auer rods)
MICROGRANULAR
Nucleus : Irregular, Folded. Mostly binucleated.
Cytoplasm : Fine small granules, “Dusky “ appearance.
Auer rods: Rare.
AML M3 , MGG x1000
CSBRP-SDUMC-Oct-2014
ACUTE MYELOMONOCYTIC LEUKEMIA
 Nearly 20% of all AML cases
 Both MYELOBLAST and MONOBLAST co exist
 M.c. Acute Leukemia in INFANTS
P.S : Both Myeloblast and monocytic components
( monoblasts, promonocytes, monocytes ) seen
Cytochemistry : monocytic cells – NSE stain
myeloid cells –Mpo/CAE stain
IFT : Monocytic component- CD64,CD14
Myeloid component- CD13,CD33,CD15
Peripheral smear
MYELOBLAST
MYELOCYTE
PROMONOCYTE
Large monocytoid cells with
Cytoplasm: Pale blue agranular
Nuclei: Ovoid to reniform
>80% of leukemic cells are monocytic lineage
• Neutrophil component may constitute <20%
• Acute monoblastic M5a Vs monocytic leukemias M5b:
PS: Monoblasts >80% in monoblastic leukemia
Promonocytes are predominant in monocytic leukemias
Cytochemistry :SBB – Fine scattered granules in monoblast
NSE – Diagnostic
IFT: CD14, CD11b, CD11c, CD64, CD68
BLOOD SMEAR BONE MARROW SMEAR
MONOBLAST
 80% or more are MONOBLAST
 Abundant cytoplasm
 Round nuclei with nucleoli
MONOBLAST WITH ABUNDANT
CYTOPLASM WITH FINE GRANULES
BLOOD SMEAR
BONE MARROW SMEAR
PROMONOCYTES
 <80% Monoblast
 Mature monocytes or
promonocytes predominate
 Def: Erythroleukemia by definition involves both the
granulocytes and erythroid cells
TYPES:
M6a Erythroleukemia
M6b PURE erythroleukemia
Erythroblast:
 Relatively high nuclear/cytoplasmic ratio
 Nucleus round with slightly condensed chromatin;
 Nucleoli variably prominent
 Deeply basophilic cytoplasm that may be vacuolated
 5% of AML cases
 More COMMONTHAN pure erythroid leukemia.
 Bimodal distribution- <20 yrs and >60yrs.
CRITERIA FOR DIAGNOSIS
 >50% of nucleated marrow cells are erythroid lineage
 >20% of nonerythroid cells are myeloblast
 Dyserythropoiesis is prominent
Cytochemistry:
MPO +ve, PAS +ve
IFT: Glycophorin A +, CD13, CD33, CD117
BLOOD SMEAR BONE MARROW SMEAR
ERYTHROID PRECURSOR
 Very rare
 Also called ERYTHEMIC MYELOSIS ,
ACUTE Di GUGLIELMO SYNDROME
 >80% of marrow cells are erythroblast
 No significant myeloblastic component
Bone marrow smear
Abnormal erythroid precursors
AML M6 Case-3 Bone marrow smear, May-Giemsa stain, x1000
History: 47year old man with a
history of renal transplant as
well as refractory anemia with
ringed sideroblasts diagnosed 1
year back.
Now he has fatigue and loss of
weight. He is on cyclosporin
and prednisolone.
Source:CAP
AML M6b case-5
Investigations:
Blood count revealed anemia and thrombocytopenia and rare
blasts.
BM revealed 81% erythroid precursors, marked dysplastic
changes and “block-and-blush” PAS positivity of erythroid
lineage. There were 12% myeloblasts and minimal dysplasia of
granulocytic cell line.
Diagnosis:
Acute erythroleukemia-M6b (pure erythroleukemia).
AML M6b case-5
Source:CAP
 10% ofAML in children & 5% of adult AML
 Bimodal distribution- Infancy and elderly
 Most common leukemia seen in Down’s Syndrome.
 May be associated with mediastinal germ cell tumors
CRITERIA FOR DIAGNOSIS
 Megakaryoblast 20% or more in BM
 Bone marrow fibrosis
MK blast:
 12-18µm
 Round nucleus with reticular
chromatin
 1-3 nucleoli
 Cytoplasm is basophilic and agranular
 Cytoplasmic blebs
 May resemble Lymphoblast
 Morphologically confused with
- L2 subtype ofALL
- AML M1.
Diagnosis depends on
Elevated serum Lactate Dehydrogenase level.
Marked leucocytosis
Cytochemistry : MPO, SBB,TdT are negative
Some scattered PAS positivity
Immunophenotyping : CD41, CD61, Gp IIb/IIIa
 Blast show distinct cytoplasmic blebs or psedopods formation
 Peripheral blood – fragments of megakaryoblast
micromegakaryocytesOr dysplastic large platelets seen
Promegakarocytes , irregular nuclei , coarse chromatin
BONE MARROW SMEAR
CSBRP-SDUMC-Oct-2014
 Favorable:
 younger age (<50)
 WBC <30,000
 t(8;21) – seen in >50% with AML M2
 inv(16) – seen in AML M4 eos
 t(15;17) – seen in >80% AML M3
 Unfavorable:
 older age (>60)
 Poor performance status
 WBC >100,000
 Elevated LDH
 prior MDS or hematogic malignancy
 CD34 positive phenotype, MRD1 postive phenotype
 del (5), del (7)
 trisomy 8
 t(6;9), t(9;22)
 t(9;11) – seen in AML M5
 FLT3 gene mutation (seen in 30% of patients)
CHRONIC MYELOID
LEUKEMIA
 CML is a clonal stem cell disorder characterised
by increased proliferation of myeloid elements at
all stages of differentiation.
 15% of leukaemias.
 It occurs most often between 40–60yrs
 Incidence increases with age, M > F.
Philadelphia chromosome
 Present in >80% of those with CML. It is a
hybrid chromosome comprising reciprocal
translocation between the long arm of
chromosome 9 and the long arm of
chromosome 22—t(9;22) forming a fusion gene
BCR/ABLon chromosome 22, which has
tyrosine kinase activity
CML is characterised by 3 distinct phases
Chronic Phase:
Proliferation of myeloid cells, which show a full range
of maturation.
Accelerated Phase: decrease in myeloid differentiation
occurs.
Blast crisis: (acute leukemia)
1) Chronic granulocytic leukemia
Classical CML with Ph chromosome +ve/ -ve
But bcr/abl 1 +ve
2) Atypical CML or Ph –ve CML
Monocytosis is intermediate b/w Classical CML & CMML
( 3-10%)
bcr/abl 1 –ve
3) Chronic myelomonocytic leukemia (CMML)
Ph –ve CML with predominance of monocytes in blood
( >10%)
Symptoms
 Asymptomatic (50% of patients)
 Fatigue
 Weight loss
 Abdominal fullness and anorexia
 Abdominal pain, esp splenic area
 Increased sweating
 Easy bruising or bleeding
Signs
 Splenomegaly (95%)
(50% of patients have a palpable spleen ≥ 10 cm BCM, Usually firm and non
tender)
 Hepatomegaly (50%)
Approximately 85%of patients are diagnosed in the chronic
phase and then progress to the accelerated and blast phases
after 3-5 years.
The diagnosis of CML is based on
Histopathologic findings in the peripheral blood
&
Philadelphia chromosome in bone marrow cells
Investigation
 CBC with differential
 peripheral blood smear
 bone marrow analysis
 US using for liver/spleen
Peripheral blood – neutrophils 20,000 - >500, 000/ L
- basphilia
-  LAP score
- blasts < 5%
- Nucleated RBCs
- Thrombocytosis
- Anaemia
 Neutrophils and Myelocytes are PREDOMINANT
cells with blasts being < 3%.
 PS shows increased Myelocytes and Mature
Polymorphs
Two basophils in blood smear
Leukemoid
reaction
CML
WBC High High
Anemia (-) (+)
PBS Shift to the Left
Toxic granulation
Dohle bodies
Shift to the left (blast)
Eosinophilia,
basophilia
LAP score High Low
Philadelphia
chromosome
(-) (+)
 Leukemias are clonal disorders
 Mutations in oncogenes is the most common
underlying pathology
 Present with: Anemia, Petichiae, infections,
hepatosplenomegaly, Lymphadenopathy
 There may be normal, low or elevated total white
count.
 AML is a heterogeneous disease
 Blast count should be 20% in BM
 There are blast equivalents
 The presence of an Auer rod is definitive
evidence of AML
 WHO classification is well accepted
 Detection of genetic abnormalities dictates
Tx and Prognosis
To
Be
Continued..

More Related Content

What's hot

Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
anil kumar g
 
Leukemia
LeukemiaLeukemia
Leukemia
Badheeb
 
Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
DrAyush Garg
 
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
Ankit Raiyani
 
Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Subhash Thakur
 
Acute leukemia lm754
Acute leukemia lm754Acute leukemia lm754
Acute leukemia lm754
Ahmad Qudah
 
Acute lymphoblastic leukemia dr narmada
Acute lymphoblastic leukemia dr narmadaAcute lymphoblastic leukemia dr narmada
Acute lymphoblastic leukemia dr narmada
Narmada Tiwari
 
Plasma cell disorders
Plasma cell disordersPlasma cell disorders
Plasma cell disorders
Vijay Shankar
 
Haemolytic anaemias
Haemolytic anaemiasHaemolytic anaemias
Haemolytic anaemias
Ibrahim khidir ibrahim osman
 
AML vs ALL 5th Semester
AML vs ALL 5th SemesterAML vs ALL 5th Semester
AML vs ALL 5th Semester
MLT LECTURES BY TANVEER TARA
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
Sansar Babu Tiwari
 
Chronic myeloid Leukemia
Chronic myeloid LeukemiaChronic myeloid Leukemia
Chronic myeloid Leukemia
MLT LECTURES BY TANVEER TARA
 
Chronic myeloid leukemia
Chronic myeloid leukemiaChronic myeloid leukemia
Chronic myeloid leukemia
DrSuman Roy
 
Non hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhuNon hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhu
Indhu Reddy
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
priya jaswani
 
Acute myeloid leukaemia
Acute myeloid leukaemiaAcute myeloid leukaemia
Acute myeloid leukaemia
Ogechukwu Uzoamaka Mbanu
 
Acute leukemias 2-csbrp
Acute leukemias 2-csbrpAcute leukemias 2-csbrp
Acute leukemias 2-csbrp
Prasad CSBR
 

What's hot (20)

Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Acute leukemia
Acute leukemiaAcute leukemia
Acute leukemia
 
Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
 
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
 
Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
 
Acute leukemia lm754
Acute leukemia lm754Acute leukemia lm754
Acute leukemia lm754
 
Acute lymphoblastic leukemia dr narmada
Acute lymphoblastic leukemia dr narmadaAcute lymphoblastic leukemia dr narmada
Acute lymphoblastic leukemia dr narmada
 
Plasma cell disorders
Plasma cell disordersPlasma cell disorders
Plasma cell disorders
 
Haemolytic anaemias
Haemolytic anaemiasHaemolytic anaemias
Haemolytic anaemias
 
Chronic Myeloid Leukaemia
Chronic Myeloid LeukaemiaChronic Myeloid Leukaemia
Chronic Myeloid Leukaemia
 
AML vs ALL 5th Semester
AML vs ALL 5th SemesterAML vs ALL 5th Semester
AML vs ALL 5th Semester
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
 
Chronic myeloid Leukemia
Chronic myeloid LeukemiaChronic myeloid Leukemia
Chronic myeloid Leukemia
 
Chronic Lymphatic Leukaemia
Chronic Lymphatic LeukaemiaChronic Lymphatic Leukaemia
Chronic Lymphatic Leukaemia
 
Chronic myeloid leukemia
Chronic myeloid leukemiaChronic myeloid leukemia
Chronic myeloid leukemia
 
Non hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhuNon hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhu
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
 
Acute myeloid leukaemia
Acute myeloid leukaemiaAcute myeloid leukaemia
Acute myeloid leukaemia
 
Acute leukemias 2-csbrp
Acute leukemias 2-csbrpAcute leukemias 2-csbrp
Acute leukemias 2-csbrp
 

Similar to Leukemias-basic pathology

Hematology slide/ Pediatric leukemia
Hematology slide/ Pediatric leukemiaHematology slide/ Pediatric leukemia
Hematology slide/ Pediatric leukemia
Dexter Baral
 
AML ALL HL NHL.pptx
AML ALL HL NHL.pptxAML ALL HL NHL.pptx
AML ALL HL NHL.pptx
chetanpattar7
 
Acute leukemias 1-csbrp
Acute leukemias 1-csbrpAcute leukemias 1-csbrp
Acute leukemias 1-csbrp
Prasad CSBR
 
acuteleukemiacomplt-161017163342.pdf
acuteleukemiacomplt-161017163342.pdfacuteleukemiacomplt-161017163342.pdf
acuteleukemiacomplt-161017163342.pdf
VandanaChandan1
 
acuteleukemiacomplt-161017163342 (1).pptx
acuteleukemiacomplt-161017163342 (1).pptxacuteleukemiacomplt-161017163342 (1).pptx
acuteleukemiacomplt-161017163342 (1).pptx
vandana thakur
 
Haematological malignancies
Haematological malignanciesHaematological malignancies
Haematological malignancies
DrAnindyo Mukhopadhyay
 
acute myeloid luekemia: Dr Arun Haldia
acute myeloid luekemia: Dr Arun Haldiaacute myeloid luekemia: Dr Arun Haldia
acute myeloid luekemia: Dr Arun Haldia
Dr Arun Haldia
 
Chronic myeloid leukemia
Chronic myeloid leukemiaChronic myeloid leukemia
Chronic myeloid leukemia
khursheed falak
 
Chronic myeloid leukemia
Chronic myeloid leukemiaChronic myeloid leukemia
Chronic myeloid leukemia
khursheed falak
 
leukemia: Aml and all by asif
leukemia: Aml and all by asifleukemia: Aml and all by asif
leukemia: Aml and all by asif
Ihsan Ullah
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamid
ayeshahmed786
 
Leukaemia.pptx
Leukaemia.pptxLeukaemia.pptx
Leukaemia.pptx
SaketKumar946153
 
MDS/MPN (2021)
MDS/MPN (2021)MDS/MPN (2021)
MDS/MPN (2021)
Ahmed Makboul
 
Aml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjjAml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjj
Asif Zeb
 
Haematopathology: An introduction to the various myeloid cell neoplasms
Haematopathology: An introduction to the various  myeloid cell neoplasmsHaematopathology: An introduction to the various  myeloid cell neoplasms
Haematopathology: An introduction to the various myeloid cell neoplasms
Qatar Cardiovascular Research Centre
 
ACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptxACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptx
chetanpattar7
 
acute myeloid leukemia - neoplastic disease.pptx
acute myeloid leukemia - neoplastic disease.pptxacute myeloid leukemia - neoplastic disease.pptx
acute myeloid leukemia - neoplastic disease.pptx
MeethuRappai1
 
Aml l6
Aml l6Aml l6
Acute leukaemia
Acute leukaemia Acute leukaemia
Acute leukaemia
NITISH SHAH
 
csf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncturecsf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncture
LincyJohny1
 

Similar to Leukemias-basic pathology (20)

Hematology slide/ Pediatric leukemia
Hematology slide/ Pediatric leukemiaHematology slide/ Pediatric leukemia
Hematology slide/ Pediatric leukemia
 
AML ALL HL NHL.pptx
AML ALL HL NHL.pptxAML ALL HL NHL.pptx
AML ALL HL NHL.pptx
 
Acute leukemias 1-csbrp
Acute leukemias 1-csbrpAcute leukemias 1-csbrp
Acute leukemias 1-csbrp
 
acuteleukemiacomplt-161017163342.pdf
acuteleukemiacomplt-161017163342.pdfacuteleukemiacomplt-161017163342.pdf
acuteleukemiacomplt-161017163342.pdf
 
acuteleukemiacomplt-161017163342 (1).pptx
acuteleukemiacomplt-161017163342 (1).pptxacuteleukemiacomplt-161017163342 (1).pptx
acuteleukemiacomplt-161017163342 (1).pptx
 
Haematological malignancies
Haematological malignanciesHaematological malignancies
Haematological malignancies
 
acute myeloid luekemia: Dr Arun Haldia
acute myeloid luekemia: Dr Arun Haldiaacute myeloid luekemia: Dr Arun Haldia
acute myeloid luekemia: Dr Arun Haldia
 
Chronic myeloid leukemia
Chronic myeloid leukemiaChronic myeloid leukemia
Chronic myeloid leukemia
 
Chronic myeloid leukemia
Chronic myeloid leukemiaChronic myeloid leukemia
Chronic myeloid leukemia
 
leukemia: Aml and all by asif
leukemia: Aml and all by asifleukemia: Aml and all by asif
leukemia: Aml and all by asif
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamid
 
Leukaemia.pptx
Leukaemia.pptxLeukaemia.pptx
Leukaemia.pptx
 
MDS/MPN (2021)
MDS/MPN (2021)MDS/MPN (2021)
MDS/MPN (2021)
 
Aml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjjAml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjj
 
Haematopathology: An introduction to the various myeloid cell neoplasms
Haematopathology: An introduction to the various  myeloid cell neoplasmsHaematopathology: An introduction to the various  myeloid cell neoplasms
Haematopathology: An introduction to the various myeloid cell neoplasms
 
ACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptxACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptx
 
acute myeloid leukemia - neoplastic disease.pptx
acute myeloid leukemia - neoplastic disease.pptxacute myeloid leukemia - neoplastic disease.pptx
acute myeloid leukemia - neoplastic disease.pptx
 
Aml l6
Aml l6Aml l6
Aml l6
 
Acute leukaemia
Acute leukaemia Acute leukaemia
Acute leukaemia
 
csf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncturecsf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncture
 

Recently uploaded

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 

Recently uploaded (20)

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 

Leukemias-basic pathology

  • 1. LEUKEMIAS Guided by: Dr.Ami shah Moderated by: Dr.Priyanka gohel Presented by: Jaimin Manek
  • 3.  Leukemia: is characterized by abnormal proliferation of blood cells,usually WBCs(Leukocytes).  Acute leukemia: rapid increase of immature blood cells.  Chronic leukemia: excessive build up of relatively mature, but still abnormal blood cells.
  • 4.  Leukemia results - From somatic mutations in the DNA. - By activating oncogenes or deactivating tumor suppressor genes. FACTORS:  Ionizing radiation  Viruses: HumanT-lymphotropic virus (HTLV-1)  Chemicals: Benzene,chemotherapy.  Smoking: slight increase in leukemia incidence.  Genetic predisposition: Down syn.,Fanconi anemia
  • 5.
  • 6. Normal hemopoiesis is finely tuned by hemostatic feedback mechanisms involving cytokines and growth factors that modulate the marrow output of red cells, granulocytes and platelets. These mechanisms are deranged in marrows involved by myeloid neoplasms. Loss of control on growth & survival and suppressor fuctions. CSBRP-SDUMC-Oct-2014
  • 7.
  • 8. Main groups: 1-Myeloid (acute / chronic) 2-Lymphoid (acute / chronic) 3-Mixed lineage leukemias CSBRP-SDUMC-Oct-2014
  • 9.
  • 10.
  • 11.
  • 12.  The most common malignant neoplasms of childhood are Leukemias  Which one is the commonest type of childhood Leukemias? AML 10% ALL 80% CML 2-3% JCML 1-2%
  • 13. Myeloblast Promyelocyte Myelocyte Metamyelocyte Band Neutrophil MATURATION Adapted and modified from U Va website Myeloid maturation:
  • 14. Two types of classifications: 1- FAB classification - degree of maturation & lineage of blasts - usage of cytochemistry & IHC 2-WHO classification - degree of maturation & lineage of blasts - Immunophenotyping - cytogenetic & molecular features - clinical outcome CSBRP-SDUMC-Oct-2014
  • 15. 1. M0: minimally differentiated 2. M1: myeloblastic leukemia without maturation 3. M2: myeloblastic leukemia with maturation 4. M3: hypergranular promyelocytic leukemia 5. M4: myelomonocytic leukemia 6. M4Eo: variant, increase in marrow eosinophils 7. M5: monocytic leukemia 8. M6: erythroleukemia (DiGuglielmo's disease) 9. M7: megakaryoblastic leukemia
  • 16. 1. AML with recurrent genetic abnormalities 2. AML and MDS 3. AML -Tx related 4. AML not otherwise categorised 5. Myeloid Sarcoma 6. Myeloid proliferation related to Down Syndrome
  • 17.  Most of the signs and symptoms are due to: 1-Anemia. 2-Leukopenia. 3-Thrombocytopenia.  Bicytopenia, Pancytopenia.  All symptoms associated with leukemia can be attributed to other diseases, consequently, leukemia is always diagnosed by laboratory investigations.
  • 18.
  • 24.  AML M0, M1, M2 : Chloromas  AML M3 : DIC  AML M4, M5 : Gum hypertrophy  AML M7 : Mediastinal mass (germ cell tumors) CSBRP-SDUMC-Oct-2014
  • 25.
  • 26. 1. CBC a. Anemia b. Trombocytopenia c. WBC High Normal Low 2. Coagulation Studies (M3-DIC) 3. Biochemical Studies
  • 27. Bone marrow (>20% blasts) - Morphology - Cytochemistry - Immunophenotyping - Cytogenetics Peripheral blood examination  blasts in almost all cases Molecular Genetic Analysis
  • 28. The diagnostic requisite of 20 percent type I and II myeloblasts in the peripheral blood or bone marrow. BLAST Equivalents: 1. In AML (M3), the predominant leukemic cell is promyelocyte 2. In AML (M5A), the predominant proliferating cell is the monoblast 3. In AML (M5B), the predominant cell is the promonocyte. 4. The megakaryoblasts of acute megakaryoblastic leukemia vary in morphology but uniformly lack the cytochemical properties of myeloblasts.CSBRP-SDUMC-Oct-2014
  • 29.  < 1% of the normal bone marrow, not observed in normal blood  Vary in size, but are usually large  Nucleus is delicate, large, round or oval, with prominent nucleoli. Stain purplish red with Wright stain. Chromatin stains evenly  Small to moderate amount of bluish nongranular cytoplasm  Three major types:Type I, II, and III
  • 30.  Fine nuclear chromatin  2 to 4 distinct nucleoli  Moderate rim of pale to basophilic cytoplasm  Without azurophilic granules Type II Delicate azurophilic granules in the cytoplasm (up to 20) Type III Numerous azurophilic granules in the cytoplasm
  • 32. CYTOLOGIC FEATURES OF BLASTS IN AML & ALL AML ALL Blast size Medium to large, uniform Variable Small to medium Cytoplasm Fine granules may be present Usually scant, a few coarse granules may be seen Auer rods Present in 60-70% of cases absent Nuclear chromatin Finely dispersed Fine to coarse Nucleoli 2-4, prominent 1-3, indistinct
  • 33. Is an azurophilic linear structure (Single or multiple) present in numerous blasts or in rare cells • Present approximately 60 to 70 % of cases of AML. • MPO, SBB, and CAE positive The presence of an Auer rod in one or more blasts is definitive evidence of AML. (The finding is not specific for any one type of AML.)
  • 34. CYTOCHEMICAL PROFILES OF ACUTE LEUKEMIAS MPO / SBB CAE NSE PAS AP ALL _ _ + / - Focally + 75% + / - Focal in T- ALL AML + + + Monocytic- diffuse - / + + MPO-myeloperoxidase, SBB-Sudan balck B, CAE-chloracetate esterase, NSE- non specific esterase, PAS-periodic acid schiff, AP-acid phosphataseCSBRP-SDUMC-Oct-2014 cvcv
  • 35.
  • 36. Myeloperoxidase (MPO) p-Phenylene diamine +Catecol + H2O2 MPO > Brown black deposits
  • 37.  It is a direct stain phospholipid in granular membrane.  Auer rods are MPO and SBB positive.
  • 38. Chloracetate (Specific) Esterase Myeloid Cell Line Naphthol-ASD-chloracetate Free naphthol compounds + Stable diazonium salt Red deposit
  • 39. FAB Immunological marker AML with minimally differentiated CD13,CD34, HLA-DR, CD33,CD117,CD2,CD7,TdT AML without maturation CD13,CD14,CD33, CD34 AML with maturation and with t(8;21) CD34,CD56 Acute promyelocytic leukemia CD13,CD33, HLA-DR absent, CD34 negative Acute myelomonocytic leukemia with abnormal eosinophils and inversion 16 CD13,CD34,CD11b,CD11c,CD14,CD33 Acute monocytic leukemia and 11q23 abnormalties CD14,CD4,CD36,CD64 Erythroleukemia Glycophorin 7,Transferrin receptor CD71 Acute Megakaryocytic leukemia cCD41,cCD42b,cCD61
  • 41.  5% of AML cases  No definite evidence of myeloid differentiation can be given by morphology & cytochemistry.  Blasts resembles M1 blast and L2 Lymphoblast PS: Large cells with pale grey blue CYTOPLASM NUCLEUS has opened fine chromatin with >= 1 nucleoli Cytochemistry: < 3% blasts reactive for MPO, SBB or NSE Immunophenotyping:  20% blasts express one or more myeloid antigens: CD13, CD14, CD33  may beTdT positive;
  • 42. AML-M0 Bone marrow smear, May-Giemsa stain, x1000
  • 43. AML M0 Bone marrow smear, cyMPO stain, x1000
  • 44. 15-20% of all AML cases M1 is differentiated from M2 by the fact that >90% blasts of non erythroid cells <10% of marrow nucleated cells are promyelocytes or more mature neutrophils PS: Blasts have variable N/C ratio with pale basophilic CYTOPLASM NUCLEUS has 1-4 nucleoli Cytochemistry:>3% blasts reactive for MPO or SBB. Immunophenotyping: Blasts express myeloid antigens: CD13, CD14, CD33.
  • 45. BLOOD SMEAR BONE MARROW SMEAR BLAST WITH PALE TO BASOPHILIC AGRANULAR CYTOPLASM , NUCLEI WITH FINE CHROMATIN & PROMINENT NUCLEOLI
  • 46. Commonest (30%) of all AML Evidence of maturation to promyelocytes and more mature neutrophils in 10 percent or more of the cells. PS: Blasts are large with pale basophilic CYTOPLASM NUCLEUS: oval to indented with 2-3 nucleoli Cytochemistry: MPO, SBB, CEA +ve Immunophenotyping: CD15, CD13, CD33 +ve In t(8,21) associated cells: Pathognomonic 40-80% are positive for CD19 20% areTdT positive
  • 47. AML M2 CASE 1 Bone marrow smear, MGG x200
  • 48. A form of AML characterized primarily by a proliferation of abnormal promyelocytes. It is usually accompanied by • DIC • t(15;17) The disease presents in two morphologic types: 1) hypergranular APL predominant cell is an abnormal promyelocyte with markedly increased and coarse azurophilic granules 2) microgranular or hypogranular APL predominant cell is an abnormal promyelocyte with diminished or small azurophilic granules.
  • 49. The most common presenting symptoms, occurring in 90 % of patients, relate to hemorrhagic manifestations and include easy bruisability, bleeding gums, hemoptysis, epistaxis, petechiae, symptoms of gastrointestinal & intracranial hemorrhage. Basic pathology is DIC.
  • 50. BONE MARROW SMEAR HYPERGRANULAR Nucleus : Folded, lobulated, granular obscure border. Cytoplasm: Prominent Azurophilic granules. Auer rods: Frequent, FAGGOT cells ( cells with bundles of auer rods)
  • 51. MICROGRANULAR Nucleus : Irregular, Folded. Mostly binucleated. Cytoplasm : Fine small granules, “Dusky “ appearance. Auer rods: Rare.
  • 52. AML M3 , MGG x1000
  • 54. ACUTE MYELOMONOCYTIC LEUKEMIA  Nearly 20% of all AML cases  Both MYELOBLAST and MONOBLAST co exist  M.c. Acute Leukemia in INFANTS P.S : Both Myeloblast and monocytic components ( monoblasts, promonocytes, monocytes ) seen Cytochemistry : monocytic cells – NSE stain myeloid cells –Mpo/CAE stain IFT : Monocytic component- CD64,CD14 Myeloid component- CD13,CD33,CD15
  • 55. Peripheral smear MYELOBLAST MYELOCYTE PROMONOCYTE Large monocytoid cells with Cytoplasm: Pale blue agranular Nuclei: Ovoid to reniform
  • 56. >80% of leukemic cells are monocytic lineage • Neutrophil component may constitute <20% • Acute monoblastic M5a Vs monocytic leukemias M5b: PS: Monoblasts >80% in monoblastic leukemia Promonocytes are predominant in monocytic leukemias Cytochemistry :SBB – Fine scattered granules in monoblast NSE – Diagnostic IFT: CD14, CD11b, CD11c, CD64, CD68
  • 57. BLOOD SMEAR BONE MARROW SMEAR MONOBLAST  80% or more are MONOBLAST  Abundant cytoplasm  Round nuclei with nucleoli MONOBLAST WITH ABUNDANT CYTOPLASM WITH FINE GRANULES
  • 58. BLOOD SMEAR BONE MARROW SMEAR PROMONOCYTES  <80% Monoblast  Mature monocytes or promonocytes predominate
  • 59.
  • 60.  Def: Erythroleukemia by definition involves both the granulocytes and erythroid cells TYPES: M6a Erythroleukemia M6b PURE erythroleukemia Erythroblast:  Relatively high nuclear/cytoplasmic ratio  Nucleus round with slightly condensed chromatin;  Nucleoli variably prominent  Deeply basophilic cytoplasm that may be vacuolated
  • 61.  5% of AML cases  More COMMONTHAN pure erythroid leukemia.  Bimodal distribution- <20 yrs and >60yrs. CRITERIA FOR DIAGNOSIS  >50% of nucleated marrow cells are erythroid lineage  >20% of nonerythroid cells are myeloblast  Dyserythropoiesis is prominent Cytochemistry: MPO +ve, PAS +ve IFT: Glycophorin A +, CD13, CD33, CD117
  • 62. BLOOD SMEAR BONE MARROW SMEAR ERYTHROID PRECURSOR
  • 63.  Very rare  Also called ERYTHEMIC MYELOSIS , ACUTE Di GUGLIELMO SYNDROME  >80% of marrow cells are erythroblast  No significant myeloblastic component
  • 64. Bone marrow smear Abnormal erythroid precursors
  • 65. AML M6 Case-3 Bone marrow smear, May-Giemsa stain, x1000
  • 66. History: 47year old man with a history of renal transplant as well as refractory anemia with ringed sideroblasts diagnosed 1 year back. Now he has fatigue and loss of weight. He is on cyclosporin and prednisolone. Source:CAP AML M6b case-5
  • 67. Investigations: Blood count revealed anemia and thrombocytopenia and rare blasts. BM revealed 81% erythroid precursors, marked dysplastic changes and “block-and-blush” PAS positivity of erythroid lineage. There were 12% myeloblasts and minimal dysplasia of granulocytic cell line. Diagnosis: Acute erythroleukemia-M6b (pure erythroleukemia). AML M6b case-5 Source:CAP
  • 68.  10% ofAML in children & 5% of adult AML  Bimodal distribution- Infancy and elderly  Most common leukemia seen in Down’s Syndrome.  May be associated with mediastinal germ cell tumors CRITERIA FOR DIAGNOSIS  Megakaryoblast 20% or more in BM  Bone marrow fibrosis MK blast:  12-18µm  Round nucleus with reticular chromatin  1-3 nucleoli  Cytoplasm is basophilic and agranular  Cytoplasmic blebs  May resemble Lymphoblast
  • 69.  Morphologically confused with - L2 subtype ofALL - AML M1. Diagnosis depends on Elevated serum Lactate Dehydrogenase level. Marked leucocytosis Cytochemistry : MPO, SBB,TdT are negative Some scattered PAS positivity Immunophenotyping : CD41, CD61, Gp IIb/IIIa
  • 70.  Blast show distinct cytoplasmic blebs or psedopods formation  Peripheral blood – fragments of megakaryoblast micromegakaryocytesOr dysplastic large platelets seen
  • 71. Promegakarocytes , irregular nuclei , coarse chromatin BONE MARROW SMEAR
  • 73.  Favorable:  younger age (<50)  WBC <30,000  t(8;21) – seen in >50% with AML M2  inv(16) – seen in AML M4 eos  t(15;17) – seen in >80% AML M3  Unfavorable:  older age (>60)  Poor performance status  WBC >100,000  Elevated LDH  prior MDS or hematogic malignancy  CD34 positive phenotype, MRD1 postive phenotype  del (5), del (7)  trisomy 8  t(6;9), t(9;22)  t(9;11) – seen in AML M5  FLT3 gene mutation (seen in 30% of patients)
  • 75.  CML is a clonal stem cell disorder characterised by increased proliferation of myeloid elements at all stages of differentiation.  15% of leukaemias.  It occurs most often between 40–60yrs  Incidence increases with age, M > F.
  • 76. Philadelphia chromosome  Present in >80% of those with CML. It is a hybrid chromosome comprising reciprocal translocation between the long arm of chromosome 9 and the long arm of chromosome 22—t(9;22) forming a fusion gene BCR/ABLon chromosome 22, which has tyrosine kinase activity
  • 77.
  • 78. CML is characterised by 3 distinct phases Chronic Phase: Proliferation of myeloid cells, which show a full range of maturation. Accelerated Phase: decrease in myeloid differentiation occurs. Blast crisis: (acute leukemia)
  • 79. 1) Chronic granulocytic leukemia Classical CML with Ph chromosome +ve/ -ve But bcr/abl 1 +ve 2) Atypical CML or Ph –ve CML Monocytosis is intermediate b/w Classical CML & CMML ( 3-10%) bcr/abl 1 –ve 3) Chronic myelomonocytic leukemia (CMML) Ph –ve CML with predominance of monocytes in blood ( >10%)
  • 80. Symptoms  Asymptomatic (50% of patients)  Fatigue  Weight loss  Abdominal fullness and anorexia  Abdominal pain, esp splenic area  Increased sweating  Easy bruising or bleeding Signs  Splenomegaly (95%) (50% of patients have a palpable spleen ≥ 10 cm BCM, Usually firm and non tender)  Hepatomegaly (50%)
  • 81. Approximately 85%of patients are diagnosed in the chronic phase and then progress to the accelerated and blast phases after 3-5 years. The diagnosis of CML is based on Histopathologic findings in the peripheral blood & Philadelphia chromosome in bone marrow cells Investigation  CBC with differential  peripheral blood smear  bone marrow analysis  US using for liver/spleen
  • 82. Peripheral blood – neutrophils 20,000 - >500, 000/ L - basphilia -  LAP score - blasts < 5% - Nucleated RBCs - Thrombocytosis - Anaemia  Neutrophils and Myelocytes are PREDOMINANT cells with blasts being < 3%.
  • 83.  PS shows increased Myelocytes and Mature Polymorphs
  • 84. Two basophils in blood smear
  • 85. Leukemoid reaction CML WBC High High Anemia (-) (+) PBS Shift to the Left Toxic granulation Dohle bodies Shift to the left (blast) Eosinophilia, basophilia LAP score High Low Philadelphia chromosome (-) (+)
  • 86.  Leukemias are clonal disorders  Mutations in oncogenes is the most common underlying pathology  Present with: Anemia, Petichiae, infections, hepatosplenomegaly, Lymphadenopathy  There may be normal, low or elevated total white count.
  • 87.  AML is a heterogeneous disease  Blast count should be 20% in BM  There are blast equivalents  The presence of an Auer rod is definitive evidence of AML  WHO classification is well accepted  Detection of genetic abnormalities dictates Tx and Prognosis
  • 88.
  • 89.